Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Molecular Partners AG
Cash from Operating Activities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Cash from Operating Activities
-CHf62m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash from Operating Activities
-$118.7m
CAGR 3-Years
11%
CAGR 5-Years
0%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Cash from Operating Activities
CHf44.6m
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash from Operating Activities
-$188.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Cash from Operating Activities
CHf10.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Cash from Operating Activities
-CHf2.4m
CAGR 3-Years
20%
CAGR 5-Years
28%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Cash from Operating Activities?
Cash from Operating Activities
-62m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Cash from Operating Activities amounts to -62m CHF.

What is Molecular Partners AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-5%

Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for Molecular Partners AG have been -5% over the past three years .

Back to Top